The packaging for biological agents-COP vial

With the continuous progress in biotechnology, genetic engineering, bioinformatics, and other fields, the innovation and development of the biopharmaceutical industry have been promoted. However, unlike chemical drugs, biological agents have their unique characteristics, such as storage conditions and drug components, thus requiring more stringent packaging requirements. The emergence of COP vials has provided an ideal packaging solution for biological agents.

RTU(ready to use) 2ml COP vial

Polymer Vial for cell and gene therapies

1. Ensuring stable drug storage: As large molecule drugs, biological agents have a more complex structure compared to small molecule drugs. Therefore, during storage, it is necessary to maintain the biological activity and stability of the drugs through a low-temperature environment to ensure efficacy. COP vials, made of cyclic olefin polymers, possess stable material properties and can withstand temperatures as low as -196°C. This means that even in a liquid nitrogen environment, such packaging still maintains good stability, providing better safety protection for drugs.

2. Reducing pharmaceutical company costs: Another aspect to consider is protein adsorption. Biological agents are generally large-molecule protein drugs, often used in fields such as oncology and cardiovascular diseases, representing high-value-added drugs. When glass comes into contact with proteins, a hydrated film forms on the surface, leading to protein adsorption. This implies that if pharmaceutical companies choose glass packaging, they need to consider the problem of imprecise dosing caused by protein adsorption, which may require increasing the filling dose to ensure drug accuracy. COP vial surfaces possess hydrophobic properties, resulting in lower protein adsorption compared to glass materials, thereby reducing pharmaceutical companies' costs of overfilling.

3. Convenience of no-wash, no-sterilization: Glass vials require complex procedures such as washing and sterilization before use, while COP vials can provide a no-wash, no-sterilization packaging method by being produced in a controlled environment. Pharmaceutical companies can use the packaging immediately upon receipt, thereby eliminating the cost investment in cleaning and sterilization equipment and improving production efficiency.

4. 
   

   From the perspective of the industry's overall environment, driven by factors such as national policy support, increasing market demand, and globalization cooperation, biological agents will experience comprehensive development. The characteristics of COP vials perfectly meet the storage requirements of biological agents and will play an irreplaceable role in the industry's development.